General Announcement::ASX:TLX FDA accepts NDA and grants priority review for Pixclara

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
24-Oct-2024 05:28:58
Status
New
Announcement Sub Title
ASX:TLX FDA accepts NDA and grants priority review for Pixclara
Announcement Reference
SG241024OTHRK0C0
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
24/10/2024 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX FDA accepts NDA and grants priority review for Pixclara

Attachments

20241024 TLX101-CDx NDA accepted vFINAL.pdf
Total size =148K